Marshall Wace, LLP Optimize Rx Corp Transaction History

Marshall Wace, LLP

$74.4 Billion
Q1 2025

A detailed history of Marshall Wace, LLP transactions in Optimize Rx Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 251,136 shares of OPRX stock, worth $3.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,136

Previous 134,446 86.79%

Holding current value

$3.1 Million

Previous $653,000 232.92%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$4.14 - $9.47 $483,096 - $1.11 Million	116,690 Added 86.79%	251,136 $2.17 Million
Q4 2024 Feb 13, 2025	BUY	$3.83 - $7.83 $514,928 - $1.05 Million	134,446 New	134,446 $653,000
Q2 2024 Aug 14, 2024	BUY	$8.8 - $13.17 $402,582 - $602,501	45,748 New	45,748 $457,000
Q3 2023 Nov 14, 2023	SELL	$7.43 - $14.96 $557,309 - $1.12 Million	-75,008 Reduced 66.89%	37,124 $288,000
Q2 2023 Aug 14, 2023	BUY	$11.63 - $15.63 $288,458 - $387,670	24,803 Added 28.4%	112,132 $1.6 Million
Q1 2023 May 15, 2023	BUY	$12.54 - $19.38 $293,950 - $454,286	23,441 Added 36.69%	87,329 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$13.77 - $22.04 $65,283 - $104,491	4,741 Added 8.02%	63,888 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $812,679 - $1.78 Million	59,147 New	59,147 $876,000
Q2 2022 Aug 15, 2022	SELL	$21.94 - $40.49 $392,111 - $723,637	-17,872 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$35.27 - $62.91 $2.2 Million - $3.92 Million	-62,292 Reduced 77.71%	17,872 $674,000
Q4 2021 Feb 14, 2022	BUY	$53.57 - $98.0 $3.92 Million - $7.18 Million	73,235 Added 1056.93%	80,164 $4.98 Million
Q2 2021 Aug 13, 2021	SELL	$42.76 - $63.33 $4.29 Million - $6.35 Million	-100,327 Reduced 93.54%	6,929 $429,000
Q1 2021 May 17, 2021	BUY	$33.36 - $62.2 $3.58 Million - $6.67 Million	107,256 New	107,256 $5.23 Million
Q2 2020 Aug 13, 2020	SELL	$8.34 - $13.69 $30,841 - $50,625	-3,698 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.71 - $11.4 $24,813 - $42,157	3,698 New	3,698 $34,000
Q3 2019 Nov 14, 2019	SELL	$13.6 - $16.96 $1.29 Million - $1.61 Million	-94,769 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.43 - $16.62 $380,434 - $606,214	36,475 Added 62.57%	94,769 $1.54 Million
Q1 2019 May 14, 2019	BUY	$10.74 - $15.59 $349,533 - $507,376	32,545 Added 126.39%	58,294 $741,000
Q4 2018 Feb 14, 2019	BUY	$9.45 - $17.82 $243,328 - $458,847	25,749 New	25,749 $282,000

Others Institutions Holding OPRX

# of Institutions

Shares Held

12.7M

Call Options Held

70.5K

Put Options Held

146K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $223M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Optimize Rx Corp Transaction History